Surgery Partners, Inc. $SGRY Shares Sold by Walleye Capital LLC

Key Points

• Walleye Capital LLC reduced its stake in Surgery Partners, Inc. by 64.4%, selling 263,592 shares and now holds 145,508 shares worth approximately $3.46 million as of the first quarter.
• Janus Henderson Group PLC boosted its holdings in Surgery Partners by 110.2% in the same quarter, owning over 11.5 million shares valued at about $244.6 million.
• The company reported a quarterly revenue of $826.20 million, surpassing analysts' estimates, while it has a consensus rating of "Moderate Buy" with an average target price of $33.00.

Walleye Capital LLC cut its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) by 64.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 145,508 shares of the company's stock after selling 263,592 shares during the period. Walleye Capital LLC owned about 0.11% of Surgery Partners worth $3,456,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also modified their holdings of the company. Janus Henderson Group PLC boosted its stake in shares of Surgery Partners by 110.2% during the 4th quarter. Janus Henderson Group PLC now owns 11,554,845 shares of the company's stock worth $244,616,000 after acquiring an additional 6,057,477 shares in the last quarter. King Street Capital Management L.P. boosted its stake in shares of Surgery Partners by 93.1% during the 4th quarter. King Street Capital Management L.P. now owns 2,800,000 shares of the company's stock worth $59,276,000 after acquiring an additional 1,350,000 shares in the last quarter. Point72 Asset Management L.P. boosted its stake in shares of Surgery Partners by 224.7% during the 4th quarter. Point72 Asset Management L.P. now owns 1,746,554 shares of the company's stock worth $36,975,000 after acquiring an additional 1,208,639 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Surgery Partners by 19.7% during the 1st quarter. Wellington Management Group LLP now owns 7,091,756 shares of the company's stock worth $168,429,000 after acquiring an additional 1,165,667 shares in the last quarter. Finally, Alpine Associates Management Inc. purchased a new stake in shares of Surgery Partners during the 1st quarter worth about $13,539,000.

Analysts Set New Price Targets

Several research firms have recently issued reports on SGRY. Bank of America began coverage on shares of Surgery Partners in a research note on Monday, July 28th. They set a "buy" rating and a $28.00 target price on the stock. Barclays lowered their target price on shares of Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 27th. Six investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

Surgery Partners Price Performance

Shares of SGRY traded down $0.03 during mid-day trading on Friday, hitting $22.69. 1,129,767 shares of the company were exchanged, compared to its average volume of 1,676,963. Surgery Partners, Inc. has a 1-year low of $18.87 and a 1-year high of $33.90. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.78 and a current ratio of 1.93. The company has a 50 day moving average of $22.36 and a 200-day moving average of $22.79. The stock has a market cap of $2.91 billion, a price-to-earnings ratio of 36.60 and a beta of 1.82.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.01. Surgery Partners had a negative net margin of 5.57% and a positive return on equity of 2.51%. The firm had revenue of $826.20 million during the quarter, compared to the consensus estimate of $816.96 million. During the same quarter in the prior year, the firm earned $0.21 EPS. The company's revenue for the quarter was up 8.4% on a year-over-year basis. Analysts expect that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.

Insider Buying and Selling at Surgery Partners

In related news, Director Teresa Deluca sold 20,018 shares of the company's stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $22.74, for a total transaction of $455,209.32. Following the completion of the transaction, the director owned 45,173 shares in the company, valued at $1,027,234.02. This represents a 30.71% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 2.70% of the stock is currently owned by company insiders.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.